Intellectual Property net (Details) - USD ($) |
9 Months Ended | 12 Months Ended | |
|---|---|---|---|
May 31, 2024 |
May 31, 2023 |
Aug. 31, 2023 |
|
| Balance - beginning | $ 462,625 | ||
| Impairment | (57,836) | $ 0 | |
| Balance - ending | 498,878 | $ 462,625 | |
| Patents [Member] | |||
| Balance - beginning | 462,625 | $ 488,462 | 488,462 |
| Addition | 119,018 | 135,862 | |
| Impairment | (57,836) | (106,761) | |
| Amortization | (24,929) | (54,938) | |
| Balance - ending | $ 498,878 | $ 462,625 | |
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accumulated amortization of intangible assets, excluding goodwill. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|